Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Seminars in Hematology|September 2, 2008
Bendamustine in chronic lymphocytic leukemia and refractory lymphomaMathias J RummelMedizinische Monatsschrift Fur Pharmazeuten|September 8, 2009
[Hairy cell leukemia: Part I: disease pattern and common therapy]Jürgen Barth, Mathias J RummelMedizinische Monatsschrift Fur Pharmazeuten|September 8, 2009
[Hairy cell leukemia: Part II: therapy with cladribine]Jürgen Barth, Mathias J RummelClinical Advances in Hematology & Oncology : H&O|April 16, 2010
Clinical Roundtable Monograph: recent advances in NHL. Highlights from the 51st ASH Annual Meeting and Exposition, December 5-8, 2009, New Orleans, LouisianaMyron S Czuczman, Mathias J RummelSeminars in Hematology|May 3, 2011
Bendamustine's emerging role in the management of lymphoid malignanciesMathias J Rummel, Stephanie A GregoryJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2009
Bendamustine: rebirth of an old drugBruce D Cheson, Mathias J RummelSeminars in Oncology|August 10, 2002
Bendamustine in the treatment of non-Hodgkin's lymphoma: results and future perspectivesMathias J Rummel, Paris S Mitrou, Dieter HoelzerInternational Journal of Hematology|June 29, 2004
Treatment of indolent non-Hodgkin's lymphoma with cladribine as single-agent therapy and in combination with mitoxantroneJames O Armitage, Kensei Tobinai, Dieter Hoelzer, et al.Seminars in Oncology|August 10, 2002
In vitro studies with bendamustine: enhanced activity in combination with rituximabMathias J Rummel, Kai U Chow, Dieter Hoelzer, et al.Leukemia & Lymphoma|April 6, 2004
Altered apoptosis pathways in mantle cell lymphomaMathias J Rummel, Sven de Vos, Dieter Hoelzer, et al.Pageof 3